ATC Group: H01AC08 Somatrogon

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of H01AC08 in the ATC hierarchy

Level Code Title
1 H Systemic hormonal preparations, excl. Sex hormones and insulins
2 H01 Pituitary and hypothalamic hormones and analogues
3 H01A Anterior pituitary lobe hormones and analogues
4 H01AC Somatropin and somatropin agonists
5 H01AC08

Active ingredients in H01AC08

Active Ingredient Description
Somatrogon

Somatrogon is a glycoprotein comprised of the amino acid sequence of hGH with one copy of the of C-terminal peptide (CTP) from the beta chain of human chorionic gonadotropin (hCG) at the N-terminus and two copies of CTP (in tandem) at the C-terminus. The glycosylation and CTP domains account for the half-life of somatrogon, which allows for weekly dosing. Somatrogon binds to the GH receptor and initiates a signal transduction cascade culminating in changes in growth and metabolism.

Related product monographs

Title Information Source Document Type  
NGENLA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

Canada (CA)

Estonia (EE)

Japan (JP)

Poland (PL)

Romania (RO)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.